Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near-Real Time: Learnings from PRISM
On October 22, the Engelberg Center for Health Care Reform hosted a roundtable webinar, “Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near Real-Time: Learnings from PRISM.”
The roundtable featured presentations from key experts on lessons learned from the implementation of the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) project, a coordinated federal strategy to monitor the safety of the 2009 H1N1 influenza vaccine using observational data from large health plans. Presenters provided an overview of PRISM and project conclusions, and described technical findings related to data infrastructure and methodological approaches. Discussion also focused on plans to integrate PRISM with the Mini-Sentinel active surveillance system.
Former Brookings Expert
Mark McClellan is a senior fellow and director of the Health Care Innovation and Value Initiative at Brookings. He has written a number of publications on care delivery reform, physician payment reform, and accountable care implementation in the U.S. and abroad.
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.